LONDON, Sept. 19, 2024 /PRNewswire/ -- Kinomica Ltd., a developer of diagnostics for precision oncology, today announces significant findings have been published in eBioMedicine demonstrating its phosphoproteomic stratification method outperforms FLT3 mutational status in predicting...
Advanced Method for Predicting Response to Midostaurin plus Chemotherapy in Acute Myeloid Leukaemia Greatly Outperforms Current Companion Diagnostic
Seaking AlphaSeeking Alpha / Seaking Alpha 11 hours ago 1 Views
Comments